ACON
Aclarion Inc (ACON)
Healthcare • NASDAQ • $2.90+0.35%
- Symbol
- ACON
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Health Information Services
- Price
- $2.90
- Daily Change
- +0.35%
- Market Cap
- $7.68M
- Trailing P/E
- N/A
- Forward P/E
- -0.57
- 52W High
- $12.03
- 52W Low
- $2.34
- Analyst Target
- $7.50
- Dividend Yield
- N/A
- Beta
- 1.22
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-pro…
Company websiteResearch ACON on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.